Brind.

Ascletis Pharma Inc. is based in Hong Kong.

Steady: 0 in the last 7 days Updated sep 8

The latest in this situation

FDA grants IND clearance for Ascletis Pharma's ASC36 study.Sep 8

How it started

3 reports, 2 independent, last reported Sep 8. The briefing below covers this first event.

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 2 outlets

Ascletis Pharma Inc. is based in Hong Kong.

Who's involved

What this event is mainly about

Hong Kong

How it developed

Newest first. Tap a step to see who reported it.

03:51Ascletis Pharma was listed on the Hong Kong Stock Exchange (HKEX) on October 1, 2026.Sub-event
Sep 8FDA grants IND clearance for Ascletis Pharma's ASC36 study.1 source
- finanznachrichten.de
Jun 23Ascletis Pharma Inc. is located in Hong Kong.1 source
- prnewswire.com

Keep exploring

The entities involved

Hong Kong
city and special administrative region of China
- Matthew Chan has been appointed head of sales at Quantcast, supporting the company's expansion in Hong Kong.02:07
- Hui commented on Singapore's regulatory approach, noting its similarity to Japan's and difference from Hong Kong's.01:06

Coverage

Newest first; wire copies grouped

Sep 8finanznachrichten.de
Jun 23prnewswire.com

1 more outlet ran the same wire story

Sep 8prnewswire.com